Novel drug extends breast cancer controlKinase inhibitor looks promising in phase II trial Adverse Reactions: Calcitonin and cancer riskHealth Canada reviewing European recommendations that restrict use of calcitonin because of evidence suggesting an increased risk of cancer. The latest in targeted tumour therapy: Aspirin Study suggests ASA helps treat certain forms of colorectal cancer Colonoscopy: Is more frequent screening better? Study suggests average-risk men get scoped every four to six years Cancer gene testing gets speedier Faster test results will influence cancer treatment decision- making, B.C. doctor says Breast cancer care: It depends where you practise Report uncovers variations in diagnosis and treatment across Canada Rising PSA: Intermittent hormone deprivation as good as continuous Pauses in prostate cancer treatment give patients relief from side-effects One year of adjuvant trastuzumab best for breast cancer Six months of treatment may be worse and two years is no better Targeted agents tackle metastatic melanoma Two-drug combo looks promising in phase II trial MDs debate merits of complementary cancer care ‘Integrative oncology’ gets government funding, but alarms skeptical physicians First Previous 40 41 42 43 44 Next Last
